Recombinant SP-A Production in E. Coli Protocol

Creative Biolabs is committed to providing flexible and robust complement-related research services for biological research institutions and scientific researchers. The optimized purification process and technical solutions allow us to seamlessly connect the front-end ordering and development systems to achieve efficient, high-quality, and low-cost delivery of finished products.

Escherichia coli can express and purify human surfactant protein A (SP-A) which lacks most of the collagen-like domain and was shown to be a partially functional trimeric unit. These recombinant fragments recognize and bind carbohydrates in a calcium-dependent manner, neutralize specific pathogenic microorganisms and exhibit certain therapeutic potential. Here, we summarize the production protocol of SP-A recombinant fragments using E. coli, which will provide effective and easy-to-obtain functional units for drug development and lung infection research.

Recombinant SP-A Production in E. Coli Protocol

Production protocol of SP-A recombinant fragments using E. coli. Fig.1 Production protocol of SP-A recombinant fragments using E. coli. (Creative Biolabs)

Creative Biolabs is always at the forefront of biotechnology, persists in learning and innovating, and is committed to providing high-quality and efficient services for life science workers. We have reached cooperation with dozens of research institutions around the world with unanimous praise. The optimized production process and comprehensive complement technology platform allow us to customize any product that meets your application needs and provide you with extremely flexible personalized choices.

Services and Product at Creative Biolabs

We look forward for you to contact us for more details. Please note that our protocols are only for your reference!

For Research Use Only.
Support

Online Inquiry